IQVIA Holdings Inc
NYSE:IQV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IQVIA Holdings Inc
NYSE:IQV
|
US |
|
I
|
Incyte Corp
DUS:ICY
|
US |
|
Vulcan Materials Co
NYSE:VMC
|
US |
|
B
|
Barratt Redrow PLC
F:3BA
|
UK |
|
H
|
Hyundai Ezwel Co Ltd
KOSDAQ:090850
|
KR |
Intrinsic Value
Is IQV undervalued or overvalued?
See the intrinsic value estimate for IQVIA Holdings Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What IQVIA Does
IQVIA Holdings helps pharmaceutical, biotech, and medical-device companies run clinical trials, manage drug data, and analyze how medicines are used in the real world. It is best known for connecting healthcare data with research services, so drug makers can design studies, recruit patients, track outcomes, and meet regulatory requirements more efficiently.
- Headquarters
- United States of America US
- Employees
- 93 000
- IPO date
- May 9, 2013
IQVIA Holdings has a narrow economic moat
Replacing IQVIA’s data and systems can require customers to rebuild connected workflows, while changing providers during an ongoing clinical trial risks costly disruption. These practical barriers help IQVIA retain customers even when competing providers offer lower prices.
Read the full moat analysis
Revenue & Expenses Breakdown
IQVIA Holdings Inc
Earnings Waterfall
IQVIA Holdings Inc
The intrinsic value for IQVIA Holdings Inc (IQV) under the Base Case is hidden USD.
Compared with the current market price of 265.82 USD, the stock appears hidden.